Zantac Generic - Search News

GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 billion

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on Wednesday.

The New York Times · 3d

Zantac’s Developer Settles Lawsuits Claiming Cancer Link

GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.

BioSpace · 2d

GSK Settles Zantac Lawsuits for $2.2B, Analysts Now Shift Focus to Vaccines

The settlement, which is at the low end of Jefferies analysts’ $2 billion to $3.5 billion estimate, will resolve 93% of the product liability cases regarding allegations that GSK’s heartburn drug could cause cancer.

FiercePharma3d

GSK will pony up $2.2B to resolve 80K Zantac cases

The agreement frees the British pharma giant from litigating 93% of the state court cases it faced in the U.S.

GSK shares jump on $2.2 billion Zantac settlement

GSK shares jumped as much as 6.5% on Thursday after the British drugmaker struck a $2.2 billion settlement over U.S. lawsuits ...

2don MSN

GSK Stock Jumps as UK Drug Giant Resolves Most US Zantac Lawsuits

GSK shares in London jumped 5% Thursday after the British drug giant said it has resolved most of the U.S. lawsuits it faced ...

2don MSN

San Antonio’s Mikal Watts among group of lawyers who settled Zantac lawsuits for up to $2.2 billion

San Antonio attorney Mikal Watts is among a group of lawyers that negotiated a settlement of as much as $2.2 billion to resolve claims by about 80,000 people who allege a discontinued version of the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results